An Umbrella Review of the Evidence of Sex Determination Procedures in Forensic Dentistry.
João Albernaz NevesNathalie Antunes-FerreiraVanessa MachadoJoão BotelhoLuís ProençaAlexandre QuintasAna Sintra DelgadoJosé João Baltazar MendesPublished in: Journal of personalized medicine (2022)
Sex determination in forensic dentistry is a major step towards postmortem profiling. The most widely recognized method is DNA, yet its application in the dental field of forensic sciences is still impractical. Depending on the conditions of the remains, teeth are often the only surviving organ. Some systematic reviews (SRs) have been recently produced; hence this umbrella review critically assesses their level of evidence and provides an overall comprehensive view. An electronic database search was conducted in four databases (PubMed, Cochrane, Web of Science, and LILACS) and three grey search engines up to December 2021, focusing on SRs of sex determination through forensic dentistry procedures. The methodological quality of the SRs was analyzed using the measurement tool to assess SRs criteria (AMSTAR2). Five SRs were included, two of critically low quality and three of low quality. The SRs posited that canines are the most dimorphic teeth; oral tissue remnants are a rich source for sex determination by DNA tracing; and artificial intelligence tools demonstrate high potential in forensic dentistry. The quality of evidence on sex determination using dental approaches was rated as low. Well-designed clinical trials and high standard systematic reviews are essential to corroborate the accuracy of the different procedures of sex determination in forensic dentistry.
Keyphrases
- solid phase extraction
- artificial intelligence
- molecularly imprinted
- clinical trial
- systematic review
- machine learning
- quality improvement
- single molecule
- deep learning
- randomized controlled trial
- emergency department
- cell free
- oral health
- white matter
- high resolution
- open label
- liquid chromatography
- mass spectrometry
- circulating tumor cells
- placebo controlled